awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q41814891-E128731C-8AFD-4F20-B1BF-381B97B6230B
Q41814891-E128731C-8AFD-4F20-B1BF-381B97B6230B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41814891-E128731C-8AFD-4F20-B1BF-381B97B6230B
Knockdown of CIP2A sensitizes ovarian cancer cells to cisplatin: an in vitro study.
P2860
Q41814891-E128731C-8AFD-4F20-B1BF-381B97B6230B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41814891-E128731C-8AFD-4F20-B1BF-381B97B6230B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8a6554cd360a239b6b2b3aee3343015ce2e81f66
P2860
CIP2A is a target of bortezomib in human triple negative breast cancer cells.